1. Home
  2. ABVX vs INFA Comparison

ABVX vs INFA Comparison

Compare ABVX & INFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABVX
  • INFA
  • Stock Information
  • Founded
  • ABVX 2013
  • INFA 1993
  • Country
  • ABVX France
  • INFA United States
  • Employees
  • ABVX N/A
  • INFA N/A
  • Industry
  • ABVX
  • INFA EDP Services
  • Sector
  • ABVX
  • INFA Technology
  • Exchange
  • ABVX Nasdaq
  • INFA Nasdaq
  • Market Cap
  • ABVX 5.3B
  • INFA 5.6B
  • IPO Year
  • ABVX N/A
  • INFA 2021
  • Fundamental
  • Price
  • ABVX $70.44
  • INFA $24.73
  • Analyst Decision
  • ABVX Buy
  • INFA Hold
  • Analyst Count
  • ABVX 7
  • INFA 13
  • Target Price
  • ABVX $74.86
  • INFA $24.75
  • AVG Volume (30 Days)
  • ABVX 3.2M
  • INFA 3.3M
  • Earning Date
  • ABVX 08-11-2025
  • INFA 08-06-2025
  • Dividend Yield
  • ABVX N/A
  • INFA N/A
  • EPS Growth
  • ABVX N/A
  • INFA N/A
  • EPS
  • ABVX N/A
  • INFA N/A
  • Revenue
  • ABVX $11,444,012.00
  • INFA $1,662,027,000.00
  • Revenue This Year
  • ABVX N/A
  • INFA $5.06
  • Revenue Next Year
  • ABVX $41.36
  • INFA $4.76
  • P/E Ratio
  • ABVX N/A
  • INFA N/A
  • Revenue Growth
  • ABVX 128.98
  • INFA 1.16
  • 52 Week Low
  • ABVX $4.77
  • INFA $15.65
  • 52 Week High
  • ABVX $75.51
  • INFA $28.14
  • Technical
  • Relative Strength Index (RSI)
  • ABVX 80.00
  • INFA 68.74
  • Support Level
  • ABVX $68.26
  • INFA $24.67
  • Resistance Level
  • ABVX $73.90
  • INFA $24.75
  • Average True Range (ATR)
  • ABVX 3.64
  • INFA 0.07
  • MACD
  • ABVX -1.64
  • INFA -0.03
  • Stochastic Oscillator
  • ABVX 46.06
  • INFA 86.84

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

About INFA Informatica Inc.

Informatica Inc provides artificial intelligence (AI) enabled data management products on a cloud native platform that connects, manages, and unifies data across multi-vendor, multi-cloud, and hybrid systems at an enterprise scale. The company's platform includes a suite of interoperable data management products that leverage the shared services and metadata of the underlying platform, including products for Data Catalog, Data Integration & Engineering, API & Application Integration, Data Quality and Observability, Master Data Management, Customer and Business 360 Applications, Governance, Access and Privacy, and Data Marketplace., allowing customers to track and understand their data. Geographically, the company generates maximum revenue from North America.

Share on Social Networks: